ΠΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΡ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ, ΡΠ²ΡΠ·Π°Π½Π½ΡΡ Ρ ΡΠ΅Π½ΡΡΠ°Π»ΡΠ½ΡΠΌ Π²Π΅Π½ΠΎΠ·Π½ΡΠΌ ΠΊΠ°ΡΠ΅ΡΠ΅ΡΠΎΠΌ, Π² ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΡΡ ΡΠ΅Π°Π½ΠΈΠΌΠ°ΡΠΈΠΈ ΠΈ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ
ΠΡΠΈ ΠΏΡΠ½ΠΊΡΠΈΠΈ ΠΈ ΠΊΠ°ΡΠ΅ΡΠ΅ΡΠΈΠ·Π°ΡΠΈΠΈ ΡΠ΅Π½ΡΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π²Π΅Π½ΠΎΠ·Π½ΠΎΠ³ΠΎ ΡΡΡΠ»Π° Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΠΏΡΠ΅Π΄ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎ Π±ΠΎΠ»ΡΡΠΈΠΌ ΡΡΠΎΠΊΠΎΠΌ ΠΊΠ°ΡΠ΅ΡΠ΅ΡΠΈΠ·Π°ΡΠΈΠΈ (Π±ΠΎΠ»Π΅Π΅ 10 Π΄Π½Π΅ΠΉ) ΠΈ Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎΡΡΡΡ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΠΠ, Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ/Π½Π΅ΠΉΡΠΎΡ ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΎΡΠΈΠ»Ρ ΡΠ»Π΅Π΄ΡΠ΅Ρ ΠΏΡΠΎΡΠ²Π»ΡΡΡ Π±ΠΎΠ»ΡΡΡΡ Π½Π°ΡΡΠΎΡΠΎΠΆΠ΅Π½Π½ΠΎΡΡΡ Π² ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ, ΡΠ²ΡΠ·Π°Π½Π½ΡΡ Ρ Π¦ΠΠ, ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ Π΄ΡΡΠ³ΠΈΠΌΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌΠΈ. ΠΠ»Ρ ΡΡΠΎΠ³ΠΎ, ΠΏΡΠΈ Π½Π°Π»ΠΈΡΠΈΠΈ Π²ΡΡΠ΅ΡΠΊΠ°Π·Π°Π½Π½ΡΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΈΡΠΊΠ° Π΄Π°Π½Π½ΠΎΠΉ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠ°Π³ΠΈΡΠΎΠ²Π° Π.Π‘. ΠΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° Π±Π°ΠΊΡΠ΅ΡΠΈΠ΅ΠΌΠΈΠΈ // Consilium-medicum. ΠΠ½ΡΠ΅ΠΊΡΠΈΠΈ. — 2002. — Π’. 1. — Π‘. 46−53.
- ΠΠ΅Π»ΠΎΠ±ΠΎΡΠΎΠ΄ΠΎΠ² Π.Π. Π ΠΎΠ»Ρ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΉ ΠΏΠΎ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ΅ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ, ΡΠ²ΡΠ·Π°Π½Π½ΡΡ Ρ ΠΊΠ°ΡΠ΅ΡΠ΅ΡΠΈΠ·Π°ΡΠΈΠ΅ΠΉ ΡΠΎΡΡΠ΄ΠΎΠ² // ΠΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΈ Π°Π½ΡΠΈΠΌΠΈΠΊΡΠΎΠ±Π½Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ 2002. — Π’. 6. — Π‘. 177−180.
- ΠΠΎΠ³Π΄Π°Π½ΠΎΠ²ΠΈΡ Π’.Π., Π‘ΡΡΠ°ΡΡΠ½ΡΠΊΠΈΠΉ Π. Π‘. ΠΡΠΏΠΈΡΠΎΡΠΈΠ½: ΡΠ½ΠΈΠΊΠ°Π»ΡΠ½ΡΠΉ Π°Π½ΡΠΈΠ±ΠΈΠΎΡΠΈΠΊ Π΄Π»Ρ ΠΌΠ΅ΡΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ // ΠΠ»ΠΈΠ½. ΠΠΈΠΊΡΠΎΠ±ΠΈΠΎΠ». ΠΠ½ΡΠΈΠΌΠΈΠΊΡΠΎΠ±. Π₯ΠΈΠΌΠΈΠΎΡΠ΅Ρ. 1999. — Π’. 1. — Π‘. 57−65.
- ΠΠ°Π»ΠΊΠΈΠ½ Π.Π., ΠΠΎΠ³Π²ΠΈΠ½ΠΎΠ² Π. Π. ΠΠ½Π°ΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠΎΠ·ΡΠ°ΡΠ½ΡΡ ΠΏΠ»Π΅Π½ΠΎΡΠ½ΡΡ Π½Π°ΠΊΠ»Π΅Π΅ΠΊ Π’Π΅Π³Π°Π΄Π΅ΡΠΌ Π² ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ΅ ΠΊΠ°ΡΠ΅ΡΠ΅Ρ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ // ΠΠ½ΡΠ΅ΠΊΡΠΈΠΈ Π² Ρ ΠΈΡΡΡΠ³ΠΈΠΈ. 2004. — Π’. 2. — Π‘. 30−32.
- ΠΠΌΠΈΡΡΠΈΠ΅Π²Π° Π.Π., ΠΠ΅ΡΡΡ ΠΎΠ²Π° Π. Π., ΠΠ°Π³ΠΈΡΠΎΠ²Π° Π. Π‘., ΠΈ Π΄Ρ. ΠΠ΅ΡΠΎΠΏΠ΅Π½Π΅ΠΌ Π² Π»Π΅ΡΠ΅Π½ΠΈΠΈ ΡΡΠΆΠ΅Π»ΡΡ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ Ρ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ // Π‘ΠΎΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ Π² ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ 2005. — Π’. 4. — Π‘. 8−13.
- ΠΠ°ΡΡΠ°Π½ A.A. ΠΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π²Π·Π³Π»ΡΠ΄ Π½Π° ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ ΠΊΠ°ΡΠ΅ΡΠ΅ΡΠ½ΡΡ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ ΠΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΡΠΉ ΡΠ΅ΡΡΡΡ. // www.rusanesth.com/genan.
- ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΌΠΈΠΊΡΠΎΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΠΊ Π°Π½ΡΠΈΠ±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΡΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ: ΠΠ΅ΡΠΎΠ΄ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠΊΠ°Π·Π°Π½ΠΈΡ ΠΠ£Π 4.2.1890−04 ΠΎΡ 04.03.2004 // ΠΠ»ΠΈΠ½. ΠΠΈΠΊΡΠΎΠ±ΠΈΠΎΠ». ΠΠ½ΡΠΈΠΌΠΈΠΊΡΠΎΠ±. Π₯ΠΈΠΌΠΈΠΎΡΠ΅Ρ. 2004. — Π’. 6. — Π‘. 306−357.
- Π ΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ ΠΏΠΎ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠΌΡ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ Π² ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ΅ / ΠΠ΅Π½ΡΠ΅Π»Ρ Π ., ΠΡΠ΅Π²Π΅Ρ Π’., ΠΡΡΡΠ»Π΅Ρ Π-Π: ΠΠ΅Ρ. Ρ Π°Π½Π³Π». Π‘ΠΌΠΎΠ»Π΅Π½ΡΠΊ: ΠΠΠΠΠΠ₯, 2003. — Π‘. 18−20.
- Π‘ΠΈΠ΄ΠΎΡΠ΅Π½ΠΊΠΎ C.B. ΠΠ½ΡΠ΅ΠΊΡΠΈΠΈ, ΡΠ²ΡΠ·Π°Π½Π½ΡΠ΅ Ρ ΡΠ΅Π½ΡΡΠ°Π»ΡΠ½ΡΠΌ Π²Π΅Π½ΠΎΠ·Π½ΡΠΌ ΠΊΠ°ΡΠ΅ΡΠ΅ΡΠΎΠΌ // ΠΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΈ Π°Π½ΡΠΈΠΌΠΈΠΊΡΠΎΠ±Π½Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ — 2001. Π’. 2, № 3. -Π‘. 24−35.
- Bailey E., Berry N., Cheesbrough J. Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis // J. Antimicrob. Chemother. 2002. — Vol. 50. — P. 615−617.
- Beekman S., Henderson D. Infections caused by percutaneous intravascular devices // Principles and practice of infectious diseases. 6th ed. / Mandell C., Bennett J., Dolin R. Philadelphia: Churchill Livingstone, 2005. — P. 33 473 361.
- Berrington A., Gould F. Use of antibiotic lokcs to treat colonized central venous catheters // J. Antimicrob. Chemoter. — 2001. Vol. 48. — P. 597 603.
- Bijma R., Girbes A., Kleijer D., Zwaveling J. Preventing central venous catheter-related infection in a surgical intensive care unit // Infect. Control Hosp. Epidemiol. 1999. — Vol. 20. — P. 618−620.
- Blankestijn N. Treatmant and prevention of catheter-related infection in hemodialysis patients // Nephrol. Dial. Transplant. 2001. — Vol. 16. — P. 1975−1978.
- Bleyer A., Mason L., Raad I., Sherertz R. A randomized, double-blind trial comparing minocycline/EDTA vs. heparin as flush solution for hemodialysis catheters //Infect. Control Hosp. Epidemiol. 1999. — Vol. 21. — P. 100.
- Blot F. Diagnosis of catheter-related infections // Catheter-Related Infections. 2nd ed. / Seifert H., Jansen B., Farr B.M., editors. New York: Marcel Dekker, 2004. — P. 37−72.
- Blot F., Nitenberg G., Chachaty E., et al. Diagnosis of catheter-related bacteremia: a prospective comparison of the time tu positivity of hub-blood versus peripheral-blood cultures // Lancet. 1999. — Vol. 354. — P. 10 711 077.
- Bong J., Kite P., Wilco M., McMahon M. Prevention of catheter related infection by silver iontophoretic central venous catheters: a randomized controlled trial//J. Clin. Pathol. 2003.-Vol. 56.-P. 731−735.
- Brun-Buisson C. New technologies and infection control practices to prevent intravascular catheter-related infections // Am. J. Resp. Crit. Care Med. -2001.-Vol. 164.-P. 1557−1558.
- Chaiyakunapruk N., Veenstra D., Lipsky Π., Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis // Ann. Intern. Med. 2002. — Vol. 136. — P. 792−801.
- Charbonneau P., du Cheyron D., Daubin C. Les defenses de l’organisme en reanimation ΠΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΡΠΉ ΡΠ΅ΡΡΡΡ. // www. infectio-lille.com.
- Chatzinikolaou I., Zipf T., Hanna H. Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer // Clin. Infect. Dis. 2003. — Vol. 36. -P. 116−119.
- Cimochowski G.E., Harostock M.D., Brown R. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics //Ann. Thorac. Surg. -2001. Vol. 71. — P. 1578−1579.
- Collin G. Decreasing catheter colonization through the use of an anticeptic-impregnated catheter // Chest. 1999. — Vol. 115. — P. 1632−1640.
- Crnich C., Maki D. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices // Clin. Infect. Dis. 2002. — Vol. 34. — P. 1232−1242.
- Crnich C., Maki D. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices // Clin. Infect. Dis.-2002.-Vol. 34.-P. 1362−1368.
- Cunha B. Intravenous line infections // Crit. Care Med. 1998. — Vol. 14. -P. 333−346.
- Darouiche R. Anti-infective efficacy of silver-coated medical prostheses // Clin. Infect. Dis. 1999.-Vol. 29.-P. 1371−1377.
- De Gaudio A., Di Filippo A. Device-related infections in critically ill patients. Part 1: prevention of catheter-related bloodstream infections // J. Chemother. -2003. Vol. 15. — P. 419−427.
- Deshpande K., Hatem C., Ulrich H., et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population // Crit. Care Med. -2005.-Vol. 33.-P. 13−20.
- Digiovine B., Chenoweth C., Watts C., Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit//Am. J. Resp. Crit. Care Med. 1999. — Vol. 160. — P. 976−981.
- Donlan R. Biofilm formation: a clinically relevant microbiological process // Clin. Infect. Dis. 2001. — Vol. 33. — P. 1387−1392.
- Droste J., Jeraj H., MacDonald A., Farrington K. Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis // J. Antimicrob. Chemother. — 2003.-Vol. 51.-P. 849−855.
- Eggiman P., Harbarth S., Constantin M., et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care // Lancet. 2000. — Vol. 355. — P. 1864−1868.
- Eggiman P., Pittet D. Epidemiology and impact of infections associated with the use of intravascular devices // Catheter-related infections. 2nd ed. /
- Seifert H., Jansen B., Farr B.M., editors. New York: Marcel Dekker, 2004. — P. 1−22.
- Elliott T. Role of antimicrobial central venous catheters for the prevention’of associated infections // J. Antimicrob. Chemother. 1999. — Vol. 43. — P. 441−446.
- Elliott T., Tebbs S. Prevention of CVC-related infection // J. Hosp. Infect. -1998.-Vol. 40.-P. 193−201.
- Farr B. Preventing vascular catheter-related infections: current controversies // Clin. Infect. Dis. -2001. Vol. 33. — P. 1733−1738.
- Finch R., Greenwood D., Norrby R., Whitley R., editors. Antibiotic and chemotherapy. 8th ed. Philadelphia: Churchill Livingstone, 2003. — P. 588 594.
- Fletcher S., Bodenham A. Safe placement of central venous catheters: where should the tip of the catheter lie? // Brit. J. Anaesth. 2000. — Vol. 85, N 2. -P. 188−191.
- Franklin J., Gaur A., Shenep J., et al. In situ diagnosis of central venous catheter-related bloodstream infection without peripheral blood culture // Pediatr. Infect. Dis. J. 2004. — Vol. 23, № 7. — P. 614−618.
- Garland J., Harris M., Alex C., et al. A randomized trial comparing povidon-iodine to chlorhexidine gluconated dressing for prevention of central venous catheter infections in neonates // Pediatrics. 2001. — Vol. 107. — P. 14 311 437.
- Gnass S., Barboza L., Bilicich.D. Prevention of central venous catheter-related bloodstream infections using non-technologic strategies // Infect. Control Hosp. Epidemiol. 2004. — Vol. 25. — P. 675−677.
- Gudlaugsson O., Gillespie S., Lee K., et al. Attributable mortality of nosocomial candidemia, revisited // Clin. Infect. Dis. — 2003. Vol. 37. — P. 1172−1177.
- Hack W., Kaste M., Bogousslavsky J., et al. Traitment de l’AVC aigu // Let. Neurol. -2001. Vol. 5. — P. 24−34.
- Hamilton-Miller J.M.T., Shan S. Patterns of phenotypic resistance to the macrolides-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci // J. Antimicrob. Chemother. 2000. — Vol. 46. — P. 941−949.
- Heard S. Catheter-related infection: diagnosis, prevention and traitment // Ann. Acad. Med. Singapore. -2001. Vol. 30. — P. 419−429.
- Hodge D., Puntis J. Diagnosis, prevention, and management of catheter related bloodstream infection during long-term parenteral nutrition // Arch. Dis. Child. Fetal Neonatal Ed. 2002. — Vol. 87. — P. 2−8.
- Inan D., Saba R., Yalcin A., et al. Device-associated nosocomial infection rates in Turkish medical-surgical intensive care units // Infect. Control Hosp. Epidemiol. 2006. — Vol. 27. — P. 343−348.
- Isenberg H. Clinucal microbiology procedures handbook. Washington: ASM Press, 1992. — P. 11.7.0−11.7.7.
- Isenberg H. Essential procedures for clinical microbiology. Washington: ASM Press, 1998. — P. 678−683.
- Jarvis W. The evolving world of healthcare-associated bloodstream infection surveillance and prevention: is your system as good as you think? // Infect. Control Hosp. Epidemiol. 2002. — Vol. 23. — P. 842−844.
- Kite P., Dobbins B., Wilcox M. Rapid diagnosis of central venous catheter-related bloodstream infections without catheter removal // Lancet. 1999. — Vol. 354.-P. 1504−1507.
- Leon C., Ruiz-Santana S., Rello J. Benefits of minocycline and rifampin-impregnated central venous catheters // Intens. Care Med. 2004. — Vol. 30. -P. 1891−1899.
- Lorente L., Henry Ch., Martin M.M., et al. Central venous catheter-related infection in a prospective and observational study of 2595 catheters // Crit. Care.-2005.-Vol. 9.-P. 631−635.
- Lorente L., Villegas J., Martin M.M., et al. Catheter-related infection in critically ill patients // Intens. Care Med. 2004. — Vol. 30. — P. 1681−1684.
- Lyte M*., Freestone P., Neal C. Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes // Lancet 2003. — Vol. 361.-P. 130−135.
- Maniatis N., Agel A., Legakis N.J., Tzouvelekis L.S. Mupirocin resistance in Staphylococcus aureus from Greek hospitals // Int. J. Antimicrob. Agents. — 2001.-Vol. 18.-P. 407−408.
- McConnell S., Gubbins P., Anaissie E. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? // Clin. Infect. Dis. 2003. — Vol. 37. — P. 65−72.
- McGee D., Gould M. Preventing complications of central venous catheterization // N. Engl. J. Med. 2003. — Vol. 348. — P. 1123−1133.
- Mclntyre C., Hulme L., Taal M., Fluck R. Locking of tunneled hemodialysis catheters with gentamicin and heparin // Kidney Int. 2004. — Vol. 66. — P. 801−805.
- Mermel L. Prevention of intravascular catheter-related infections // Ann. Intern. Med.-2000.-Vol. 132.-P. 391−402.
- Mermel L.A., Farr B.M., Sherertz R.J., et al. Guidelines for the management of intravascular catheter-related infections // Clin. Infect. Dis. 2001. — Vol. 32.-P. 1249−1272.
- Mickley V. Central venous catheters: many questions, few answers // Nephrol. Dial. Transplant. 2002. — Vol. 17. — P. 1368−1373.
- Miller D., O’Grady N. Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology// J. Vase. Intervent. Rad. -2003. Vol. 14. — P. 133−136.
- Mimoz O., Karim A., Mercat A., et al. Clorhexidine compared with povidon-iodine as skin preparation befor blood cultur: a randomized, controlled trial //Ann. Intern. Med. 1999.-Vol. 131.-P. 834−837.
- Munoz P., Bouza E., San Juan R. Clinical-epidemiological characteristics and outcome of patients with catheter-related bloodstream infections in Europe (ESGNI-006 Study) // Clin. Microbiol. Infect. 2004. — Vol. 10. — P. 843−845.
- Nucci M., Anaissie E. Should vascular catheters be removed from all patients with candidemia? An evidence-based review // Clin. Infect. Dis. -2002.-Vol. 34.-P. 591−599.
- O’Grady N., Alexander M., Dellenger E., et al. Gudelines for the prevention of intravascular catheter-related infections // Clin. Infect. Dis. 2002. — Vol. 35.-P. 1281−1307.
- O’Leary M., Bihari D. Central venous catheters-time for a change? // Brit. Med. J. 1998. — Vol. 316. -P. 1918−1919.
- O’Neill A.J., Cove J.H., Chopra I. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus II J. Antimicrob. Chemother. 2001. — Vol. 47. — P. 647−650.
- Polderman K.H. Girbes A.RJ. Central venous catheter use. Part 1: Mechanical complications // Intens. Care Med. 2002. — Vol. 28. — P. 1−17.
- Polderman K.H. Girbes A.RJ. Central venous catheter use. Part 2: Infectious complications // Intens. Care Med. 2002. — Vol. 28. — P. 18−28.
- Poole C., Carlton D., Bimbo L., Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen // Nephrol. Dial. Transplant. 2004. — Vol. 19. — P. 1237−1244.
- Pracchia L., Dias L., Dorlhiac-Lacer P., Chamone D. Comparison of catheter-related infection risk in two different long-term venous device in adult hematology-oncology patients // Rev. Hosp. Clin. Med. S. Paulo. -2004.-Vol. 5.-P. 291−295.
- Raad I. Management of intravascular catheter-related infections // J. Antimicrob. Chemother. 2000. — Vol. 45. — P. 267−270.
- Raad I., Hachem R., Tcholakian R., Sherertz R. Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septicphlebitis, and endocarditis in rabbits // Antimicrob. Agents Chemother. -2002. Vol. 46. — P. 327−332.
- Raad I., Hanna H., Alakech B. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections // Ann. Intern. Med. 2004. — Vol. 140.-P. 18−25.
- Renaud B., Brun-Buisson C. Outcomes of primary and catheter-related bacteremia // Am. J. Resp. Crit. Care Med. 2001. — Vol. 163. — P. 15 841 590.
- Richards M., Edwards J., Culver D., Gaynes R. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System // Crit. Care Med. 1999. — Vol. 27. — P. 887−892.
- Rijnders B.', Wijngaerden E., Wilmer A., Peetermans W. Use of full sterile barrier precautions during insertion of arterial catheters: a randomized trial // Clin. Infect. Dis. 2003. — Vol. 36. — P. 743−748.
- Rodriguez-Bano J. Selection of empiric therapy in patients with catheter-related infections // Clin. Microbiol. Infect. 2002. — Vol. 8. — P. 275−281.
- Rohani M.Y., Raudzah A., Lau M.G. Susceptibility pattern of Staphylococcus aureus isolated in Malaysian hospitals // J. Antimicrob. Agents. -2000. Vol. 13. — P. 209−213.
- Rosenthal V., Maki D., Salomao R., et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries // Ann. Intern. Med. 2006. — Vol. 145.-P. 582−591.
- Safdar N., Fine J., Maki D. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection // Ann. Intern. Med. — 2005. Vol. 142. — P. 451−466.
- Safdar N., Maki D. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters // Intens. Care Med. 2004. — Vol. 30. — P. 62−67.
- Saint S., Savel R., Matthay M. Enhancing the safety of critically patients by reducing urinary and central venous catheter-related infections // Am. J. Resp. Crit. Care Med. 2002. — Vol. 165.-P. 1475−1479.
- Samra Z., Gadba R., Ofir O. Antibiotic susceptibility and phage typing of methicillin-resistant and sensitive Staphylococcus aureus clinical isolates at period during 1991−1997 // Eur. J. Clin. Microbiol. Infect. Dis. 2001. -Vol. 20.-P. 427−437.
- Sandoe J., Witherden I., Au-Yeung H. Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases // J. Antimicrob. Chemother. 2002. — Vol. 50. — P. 577−582.
- Sandoe J., Wysome J., West A., et al. Mesurement of ampicillin, vancomycin, linesolid and gentamicin activity against enterococcal biofilms // J. Antimicrob. Chemother. 2006. — Vol. 57. — P. 767−770.
- Seifert H., Jansen B., Widmer A.F., Farr B.M. Central-venous catheters// Catheter-related infections. 2nd ed. / Seifert H., Jansen B., Farr B.M., editors. New York: Marcel Dekker, 2004. — P. 293−315.
- Shah C., Mittelman M., Costerton J., et al. Antimicrobial ativity of a novel catheter lock solution // Antimicrob. Agent. Chemother. 2002. — Vol. 46. -P. 1674−1679.
- Sherertz R. Pathogenesis of vascular catheter infections// Catheter-related infections. 2nd ed. / Seifert H., Jansen B., Farr B.M., editors. New York: Marcel Dekker, 2004. — P. 23−36.
- Sherertz R., Bleyer A., Mason L., Raad I. In vitro efficacy of minocycline/EDTA as a catheter lock solution // SHEA. 2002. — Vol. 56. -106−111.
- Sherertz R., Ely W., Westbrook D., et al. Education of physicians-in-training can decrease the risk for vascular catheter infection // Arm. Intern. Med. — 2000. Vol. 132. — P. 641−648.
- Schierholz J., Fleck C., Beuth J., Pulverer G. The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity // J. Antimicrob. Chemother. 2000. — Vol. 46. — P. 45−50.
- Slaughter S. Intravascular catheter-related infections // Postgrad. Med. -2004.-Vol. 116.-P. 59−66.
- Sulavic M.C., Barg N.L. Examination of methicillin-resistant and methicillin-susceptible Staphylococcus aureus mutants with low-level fluoroquinolone resistance // Antimicrob. Agent. Chemother. — 1998. — Vol. 12.-P. 3317−3319.
- Thomas D.G., Hann A.C., Day M.J. Structural changes induced by mupirocin in Staphylococcus aureus cells // Atimicrob. Agents Chemother. — 1999.-Vol. 13.-P. 9−14.
- Turnidge J., Collignon P. Resistance to fusidic acid // Int. J. Antimicrob. Agents. 1999. — Vol. 12. — P. 35−44.
- Veenstra D., Saint S., Saha S. Efficacy of anticeptic-impregnated central venous catheters in preventing catheter-related bloodstream infection // JAMA. 1999. — Vol. 281. — P. 261−267.
- Viale P., Petrosillo N., Signorini L. Should lock therapy always be avoided for central venous catheter-associated fungal bloodstream infections? // Clin. Infect. Dis. -2001. Vol. 33. — P. 1947−1948.
- Vinjirayer A., Jefferson P., Ball D. Securing central venous catheters: a comparison of sutures with staples // Emerg. Med. J. 2004. — Vol. 21. — P. 582−583.
- Vonberg R., Behnke M., Geffers C., et al. Device-associated infection rates for non-intensive care unit patients // Infect. Control Hosp. Epidemiol. — 2006. Vol. 27. — P. 357−361.
- Walsh T., Rex J. All catheter-related candidemia is not the same: assessment of the balance between the risks and benefits of removal of vascular catheters // Clin. Infect. Dis. 2002. — Vol. 34. — P. 600−602.
- Warren D., Zack J., Elward A. Nosocomial primary bloodstream infections in intensive care unit patients in a nonteaching community medical center: a 21-month prospective study // Clin. Infect. Dis. 2001. — Vol. 33. — P. 13 291 335.
- Warren D., Zack J., Mayfield J., et al. The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU//Chest. 2004. — Vol. 126.-P. 1612−1618.
- Worthington T., Lambert P., Elliott T. A novel serological test for the laboratory diagnosis of central venous catheter-associated sepsis // J. Antimicrob. Chemother. 2000. — Vol. 46. — P. 516.
- Yoo S., Ha M., Choi D., Pai H. Effectiveness of surveillance of central catheter-related bloodstream infection in an ICU in Korea // Infect. Control Hosp. Epidemiol. 2001. — Vol. 22. — P. 433−436.
- Yucel N., Lefering R., Maegele M., et al. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial // J. Antimicrob. Chemother. 2004. — Vol. 34. — P. 126−142.
- Zolldann D., Spitzer C., Hafner H., et al. Surveillance of nosocomial infections in a neurologic intensive care unit // Infect. Control Hosp. Epidemiol. 2005. — Vol. 26. — P. 726−731.